HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION DIN 02329468
Health Canada record
| Active ingredient(s) | INDIUM IN 111 CHLORIDE 10 MCI |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | UNASSIGN UNASSIGNED |
| Original market date | 08-Sep-2019 |
| Current status date | 28-Feb-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Curium Canada Inc. — licence 3-002566, currently licensed, last inspection rating C (2026-07-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INDIUM IN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02329271 | OCTREOSCAN | CURIUM CANADA INC | Powder For Solution; Solution; Kit | INDIUM IN 111 CHLORIDE 111 MBq; PENTETREOTIDE 10 MCG | Marketed |
| 02329077 | INDIUM IN-111 CHLORIDE STERILE SOLUTION | GE HEALTHCARE CANADA INC | Solution | INDIUM IN 111 CHLORIDE 74 MBq | Cancelled Pre Market |
| 02329085 | INDIUM IN-111 CHLORIDE STERILE SOLUTION | GE HEALTHCARE CANADA INC | Solution | INDIUM IN 111 CHLORIDE 185 MBq | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22094 | 2019-04-26 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for INDIUM IN
1 active FDA Drug Master Files.
Request a quote for HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION